RE:My take on great news muted share priceHey balain, I share your frustration. based on all the very positive PRs over the last year, I thought the sp should be closer to $4 than today's price. The issue has been the overhang of the weak B/S. Everybody knows this. One thing that has come thru in all my communications with the company is that fixing the B/S is the number one priority.
Q3 results are due by mid November. There is no doubt that this issue will come up and management will have to provide insight as to how it expects to finance operations until it is cashflow positive in 2019. So not long to wait.
Like you, I believe that it is possible if not likely that Thomvest will step up to the plate. I don't know whether this will be in the form of a loan or equity. I prefer a loan, in anticipation of PLI closing partnership/licencing deals. While PLI's hand in negotiations may appear to be slightly weakened because of its financial situation, this is likely to be more than offset by the fact that several very large pharmas are likely tusseling with each other to get the rights to 4050 for IPF. We also can't exclude scope for regional deals on Pg either and PLI's hand has been strengthened with yesterday's news. The prospect of a voucher is a wonderful wild card to have.
Let's see what happens over the next few weeks or months. I am hopeful that PLI will access all the rocket fuel it needs to get us to the moon.